Table of Content

1 INTRODUCTION
1.1 Study Assumptions
1.2 Scope of the Study


2 RESEARCH METHODOLOGY


3 EXECUTIVE SUMMARY


4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increase in Obesity Patients
4.2.2 Rising Prevalence of Type 2 Diabetes and Heart Diseases
4.2.3 Government Initiatives to Curb Obesity
4.3 Market Restraints
4.3.1 High Cost of Surgery
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry


5 MARKET SEGMENTATION
5.1 By Device
5.1.1 Assisting Devices
5.1.1.1 Suturing Device
5.1.1.2 Closure Device
5.1.1.3 Stapling Device
5.1.1.4 Trocars
5.1.1.5 Other Assisting Devices
5.1.2 Implantable Devices
5.1.2.1 Gastric Bands
5.1.2.2 Electrical Stimulation Devices
5.1.2.3 Gastric Balloons
5.1.2.4 Gastric Emptying
5.1.3 Other Devices


6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Cousin Biotech
6.1.2 Reach surgical
6.1.3 Olympus Corporation
6.1.4 ReShape Lifesciences, Inc
6.1.5 Obalon Therapeutics
6.1.6 TransEnterix Inc
6.1.7 USGI Medical


7 MARKET OPPORTUNITIES AND FUTURE TRENDS